241 related articles for article (PubMed ID: 25150608)
1. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
Watson R; Wearmouth E; McLoughlin AC; Jackson A; Ward S; Bertram P; Bennaceur K; Barker CE; Pappworth IY; Kavanagh D; Lea SM; Atkinson JP; Goodship TH; Marchbank KJ
Mol Immunol; 2015 Feb; 63(2):287-96. PubMed ID: 25150608
[TBL] [Abstract][Full Text] [Related]
2. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
3. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
Foltyn Zadura A; Zipfel PF; Bokarewa MI; Sturfelt G; Jönsen A; Nilsson SC; Hillarp A; Saxne T; Trouw LA; Blom AM
Arthritis Res Ther; 2012 Aug; 14(4):R185. PubMed ID: 22894814
[TBL] [Abstract][Full Text] [Related]
4. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
5. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
Guo WY; Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2019 Feb; 34(2):269-281. PubMed ID: 30315407
[TBL] [Abstract][Full Text] [Related]
6. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
[TBL] [Abstract][Full Text] [Related]
7. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
Cugno M; Berra S; Depetri F; Tedeschi S; Griffini S; Grovetti E; Caccia S; Cresseri D; Messa P; Testa S; Giglio F; Peyvandi F; Ardissino G
J Am Soc Nephrol; 2021 May; 32(5):1227-1235. PubMed ID: 33712527
[TBL] [Abstract][Full Text] [Related]
8. Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007-2012.
Åkesson A; Blom AM; Klintman J; Zetterberg E
Nephrology (Carlton); 2017 Jul; 22(7):555-561. PubMed ID: 27175932
[TBL] [Abstract][Full Text] [Related]
9. Complement Factor I Variants in Complement-Mediated Renal Diseases.
Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
Front Immunol; 2022; 13():866330. PubMed ID: 35619721
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
[TBL] [Abstract][Full Text] [Related]
11. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.
Volokhina EB; Westra D; van der Velden TJ; van de Kar NC; Mollnes TE; van den Heuvel LP
Clin Exp Immunol; 2015 Aug; 181(2):306-13. PubMed ID: 25079699
[TBL] [Abstract][Full Text] [Related]
12. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
[TBL] [Abstract][Full Text] [Related]
13. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
14. Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome.
Gurjar BS; Manikanta Sriharsha T; Bhasym A; Prabhu S; Puraswani M; Khandelwal P; Saini H; Saini S; Verma AK; Chatterjee P; Guchhait P; Bal V; George A; Rath S; Sahu A; Sharma A; Hari P; Sinha A; Bagga A
Immunology; 2018 Feb; 154(4):663-72. PubMed ID: 29485195
[TBL] [Abstract][Full Text] [Related]
15. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.
Strobel S; Hoyer PF; Mache CJ; Sulyok E; Liu WS; Richter H; Oppermann M; Zipfel PF; Józsi M
Nephrol Dial Transplant; 2010 Jan; 25(1):136-44. PubMed ID: 19666655
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
Nozal P; Bernabéu-Herrero ME; Uzonyi B; Szilágyi Á; Hyvärinen S; Prohászka Z; Jokiranta TS; Sánchez-Corral P; López-Trascasa M; Józsi M
Mol Immunol; 2016 Feb; 70():47-55. PubMed ID: 26703217
[TBL] [Abstract][Full Text] [Related]
18. Anti-complement-factor H-associated glomerulopathies.
Durey MA; Sinha A; Togarsimalemath SK; Bagga A
Nat Rev Nephrol; 2016 Sep; 12(9):563-78. PubMed ID: 27452363
[TBL] [Abstract][Full Text] [Related]
19. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
[TBL] [Abstract][Full Text] [Related]
20. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
Józsi M; Strobel S; Dahse HM; Liu WS; Hoyer PF; Oppermann M; Skerka C; Zipfel PF
Blood; 2007 Sep; 110(5):1516-8. PubMed ID: 17495132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
